Welcome to the
American Society of Breast Surgeons
The American Society of Breast Surgeons is committed to continually improving the practice of breast surgery by serving as an advocate for those who seek excellence in the care of breast patients.
Member Directory - Find a member
Mastery of Breast Surgery Program Registered Participants: Sign in Here
Nipple Sparing Mastectomy Registry
Click Here for Information
Our Foundation - Visit our Foundation web site for more information.
ASBrS Mourns the Passing of Professor Umberto Veronesi
The Society is saddened by the passing of lifetime member Professor Umberto Veronesi. Professor Veronesi was the keynote speaker at the Society's 2007 annual meeting and was a global leader in the treatment of breast disease. We extend our deepest condolences to his family and friends.
Call for "How I Do It" Videos Deadline 12/6
"A picture is worth a thousand words." Certainly, for surgeons a video can often educate better than other formats. So this year The American Society of Breast Surgeons (ASBrS) is again inviting YOU to submit a video showing your colleagues your tricks of the trade. Your video can be used to demonstrate how you perform a novel procedure, provide tips or tricks you use on a standard procedure, or show an approach you take to a clinical problem. To have your video considered for presentation, it must be submitted no later than 3:00 pm ET on December 6, 2016.
Questions regarding the submission process for abstracts and "How I Do It" videos should be emailed to email@example.com. For more information on guidelines and submission, visit the "How I Do It" Video Submissions page.
Society Releases Consensus Guideline on Concordance Assessment of Image-Guided Breast Biopsies and Management of Borderline or High-Risk Lesions
The American Society of Breast Surgeons has released a consensus guideline on Concordance Assessment of Image-Guided Breast Biopsies and Management of Borderline or High-Risk Lesions. This statement was developed by the Society's Research Committee and approved by the Board of Directors. The guideline replaced the previous version from 2011.
Society Releases Consensus Guideline on Hereditary Genetic Testing for Patients With and Without Breast Cancer
The American Society of Breast Surgeons has released a consensus guideline on Hereditary Genetic Testing for Patients With and Without Breast Cancer. This statement was developed by the Society's Research Committee and approved by the Board of Directors. The guideline replaced the previous statement, BRCA Genetic Testing for Patients.
Deadline to Complete BESAP I has been extended to January 15, 2017
BESAP I users (current and new purchasers) will now have until January 15, 2017, to complete BESAP I (BESAP I expires on January 16, 2017).
To access your BESAP account, please log into your user account(above right). Once you are logged in, click the 'Education' tab and select 'BESAP'.
Not a BESAP I User? Do you want to evaluate your mastery of critical content for the diagnosis and treatment of breast disease? Do you need to obtain the self-assessment credits necessary to fulfill the ABS Maintenance of Certification Part 2 requirements for Recertification? Buy BESAP I today!
For more information and to purchase BESAP I, click here.
BESAP II to Launch Early 2017
Mark your calendars - BESAP II is launching early 2017! More details will be available fall 2016 here on the Society's website. Questions about BESAP? Please contact Tekoah White at firstname.lastname@example.orgThe American Society of Breast Surgeons is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
ASBrS Consensus Panel Recommends Against Routine Use of Contralateral Prophylactic Mastectomy
On July 28, 2016, the Society released a position statement recommending against contralateral prophylactic mastectomy (CPM) for average risk women with unilateral breast cancer. The statement was published as two manuscripts in the Annals of Surgical Oncology which are available open access online at http://dx.doi.org/10.1245/s10434-016-5443-5 and http://dx.doi.org/10.1245/s10434-016-5408-8.
ASBrS encourages an evidence-based approach to determine the value of CPM in breast cancer patients. Although CPM may be appropriate for certain high-risk groups, research reveals that the majority of women with breast cancer obtain no oncological benefit from removal of a healthy breast. The statement follows extensive research including a consensus conference held during the Society's 2016 Annual Meeting. For more information, click here.
Interested in Applying for Membership?